BioPharm America is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

September 11-12, 2019|Boston Convention & Exhibition Center,Boston, MA

Partnering opportunities for innovative life science leaders

Drive breakthroughs in drug development through networking and partnering at BioPharm America

The Ultimate Biopharma Dealmakers Report for Alliances and M&As, Second Edition 2016–2019

Download this in-depth report for the details of these game-changing deals and what they indicate for the future of the biopharma industry.

Your Opportunity to engage with global life science partners

BioPharm America attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.

What do I get access to?
  • Two full days of programming
  • Full access to partnering (powered by partneringONE®)
  • Access to Biotech Week Boston parties and informal networking
    • Your chance to meet the greater life science community of 4,500+ global biopharma companies
Register now
Gain insight

Hear key biotech and pharma leaders discuss the latest industry trends in workshops and panels.

Attend five Xcelerate Keynote presentations by high-level industry experts in oncology, gene therapy, translational medicine and more.

View the agenda

Special offer for Startups!

Build new relationships, that will help you to get ahead. Engage with high-caliber strategic partners and investors to advance your startup company.

SPONSORSHIP OPPORTUNITIES

Leverage custom opportunities to engage attendees in-person and through digital campaigns. Whether you want to reinforce your thought leadership, build your brand, generate leads, or shake hands with new partners – we have you covered!

The Ultimate Biopharma Dealmakers Report for Alliances and M&As, Second Edition 2016–2019


Over the past 3 years, biopharma companies have inked more than 500 alliances where potential deal value of more than $50 million was disclosed. In this second edition, Chris Morrison expands on his analysis of game-changing deals with the addition of the most recent mega-deals as well as the aggregate effects of all alliances and acquisitions. 

What's inside:

  • Biopharma Alliance Trends
  • Biopharma M&A Trends
  • Top 10 Alliances by upfront deal value
  • Top 16 M&A by upfront deal value 

DOWNLOAD NOW >>


Get the latest event updates

Sign up to get the latest event updates and information.